ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation

FEBS Letters

Volumn 582, Issue 12, 2008, Pages 1637-1642

  Shao, Jieya ^a   Welch, William J ^a   Diamond, Marc I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen receptor; Huntingtin; Neurodegeneration; Polyglutamine; PRK 2; ROCK

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANDROGEN RECEPTOR; FASUDIL; HUNTINGTIN; POLYGLUTAMINE; PROTEIN KINASE B BETA; RHO KINASE; RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DROSOPHILA; DRUG INHIBITION; EMBRYO; HUMAN; HUMAN CELL; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

AMIDES; ANIMALS; CELL LINE; DROSOPHILA; HUMANS; HUNTINGTON DISEASE; MUSCLE RELAXANTS, CENTRAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; RNA INTERFERENCE;

EID: 43549084329     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.009     Document Type: Article

References (31)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
2. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
3. Pollitt S.K., Pallos J., Shao J., Desai U.A., Ma A.A., Thompson L.M., Marsh J.L., and Diamond M.I. A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40 (2003) 685-694
4. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4 (2003) 446-456
5. Amano M., Fukata Y., and Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261 (2000) 44-51
6. Mueller B.K., Mack H., and Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug Discov. 4 (2005) 387-398
7. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
8. Vincent S., and Settleman J. The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization. Mol. Cell Biol. 17 (1997) 2247-2256
9. Mukai H. The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J. Biochem. 133 (2003) 17-27
10. Ishizaki T., Naito M., Fujisawa K., Maekawa M., Watanabe N., Saito Y., and Narumiya S. p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett. 404 (1997) 118-124
11. Leung T., Chen X.Q., Manser E., and Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell Biol. 16 (1996) 5313-5327
12. Desai U.A., Pallos J., Ma A.A., Stockwell B.R., Thompson L.M., Marsh J.L., and Diamond M.I. Biologically active molecules that reduce polyglutamine aggregation and toxicity. Hum. Mol. Genet. 15 (2006) 2114-2124
13. Sasaki Y., Suzuki M., and Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol. Ther. 93 (2002) 225-232
14. Ikenoya M., Hidaka H., Hosoya T., Suzuki M., Yamamoto N., and Sasaki Y. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J. Neurochem. 81 (2002) 9-16
15. Amano M., Chihara K., Nakamura N., Kaneko T., Matsuura Y., and Kaibuchi K. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J. Biol. Chem. 274 (1999) 32418-32424
16. Nakagawa O., Fujisawa K., Ishizaki T., Saito Y., Nakao K., and Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 392 (1996) 189-193
17. Weiss W.A., Taylor S.S., and Shokat K.M. Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat. Chem. Biol. 3 (2007) 739-744
18. Wettschureck N., and Offermanns S. Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J. Mol. Med. 80 (2002) 629-638
19. Bito H., et al. A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron 26 (2000) 431-441
20. Katoh H., Aoki J., Ichikawa A., and Negishi M. p160 RhoA-binding kinase ROKalpha induces neurite retraction. J. Biol. Chem. 273 (1998) 2489-2492
21. Hirose M., et al. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141 (1998) 1625-1636
22. Arimura N., et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J. Biol. Chem. 275 (2000) 23973-23980
23. Hara M., Takayasu M., Watanabe K., Noda A., Takagi T., Suzuki Y., and Yoshida J. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats. J. Neurosurg. 93 (2000) 94-101
24. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., and McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22 (2002) 6570-6577
25. Fournier A.E., Takizawa B.T., and Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23 (2003) 1416-1423
26. Tanaka H., Yamashita T., Yachi K., Fujiwara T., Yoshikawa H., and Tohyama M. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience 127 (2004) 155-164
27. Zhou Y., et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 302 (2003) 1215-1217
28. Takanashi, Y., Ishida, T., Meguro, T., Kiwada, H., Zhang, J.H. and Yamamoto, I. (2001) Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 48, 894-900 (discussion 900-1).
29. Tachibana E., Harada T., Shibuya M., Saito K., Takayasu M., Suzuki Y., and Yoshida J. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir. (Wien) 141 (1999) 13-19
30. Fukata Y., Amano M., and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22 (2001) 32-39
31. Meriin A.B., Zhang X., Alexandrov I.M., Salnikova A.B., Ter-Avanesian M.D., Chernoff Y.O., and Sherman M.Y. Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains. Faseb J. 21 (2007) 1915-1925